New algorithm/tool used to achieve the periodontal risk assessment, diagnosis and prognosis (GF-PeDRA©): A clinical study with 221 patients.
Аннотация
BACKGROUND
Periodontal diagnosis and risk assessment are extremely important to assess the individual likelihood of developing periodontal disease or experiencing its progression.
OBJECTIVES
The goal was to introduce and validate a new algorithm through providing the periodontal/ peri-implant diagnosis (comparing the one by the professionals vs. the automated tool), risk assessment and prognosis, and to establish cut-off limits with a new scoring system.
MATERIAL AND
METHODS
GF-PeDRA© has 18 parameters to be assessed, achieving an octadecagon picture. The parameters are as follows: the probing depth (PD); the number of interproximal sites with bone loss; clinical attachment loss (CAL); radiographic bone loss (RBL); bleeding on probing (BoP); the bone loss pattern; tooth loss; the evidence of progression; the need for complex rehabilitation; the patient's age; biofilm accumulation; smoking; diabetes; extension and distribution; peri-implant disease; other systemic conditions; furcation involvement; and necrotizing lesions. The new scoring system, GF-PeDRA©, is based on the percentage of the octadecagon area obtained: for areas ≥0% and ≤9%, the prognosis is good; ≥10% and ≤24%, fair; ≥25% and ≤37%, poor; ≥38% and ≤49%, questionable; and ≥50%, hopeless.
RESULTS
A total of 221 patients were included, with 34 (15.38%) smokers and 28 (12.67%) diabetics. The evaluators individually achieved the diagnosis (κ = 0.83); therefore, 37 out of 221 cases were revised, and the final clinical diagnosis was established. Afterward, all information was inserted into GF-PeDRA© to obtain an automated diagnosis. Comparing them (the professionals vs. GF-PeDRA©), the total agreement level was achieved (κ = 1.0). The average GF-PeDRA© score was 28.64%, with a median (Me) of 32.2%. Forty-eight (21.72%) patients were classified as having a good prognosis for periodontal treatment, 43 (19.46%) had a fair prognosis, 43 (19.46%) had a poor prognosis, 68 (30.77%) had a questionable prognosis, and 19 (8.60%) had a hopeless prognosis.
CONCLUSIONS
GF-PeDRA© proved to be a helpful tool in diagnosing, and providing risk assessment and prognosis. New clinical studies must be conducted to validate the presented GF-PeDRA© scoring system.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.